

Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2125|80|4|765-767
ISSN: 0306-5251
Source: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.4, 2015-10, pp. : 765-767
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Vemurafenib/dabrafenib and trametinib
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. :




JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. :




Dabrafenib‐induced pemphigoid‐like reaction
CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 43, Iss. 2, 2018-03 ,pp. :